Current Funding Opportunities Update

Read in Browser Current Funding Opportunities Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) 04/06/2021 This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective cell replacement therapies for type 1 diabetes (T1D). The purpose is to support research leading to the development and testing of novel and supportive technologies for the improvement of cell replacement interventions using novel biomaterials and devices for T1D treatment. Xiaodu Guo, M.D., Ph.D. | RFA-DK-21-006 Limited Competition: Revision to the Longitudinal Monitoring of Pancreas Architecture in the Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional) 04/05/2021 This Funding Opportunity Announcement (FOA) invites one application from the Program Director/Principal Investigator (PD/PI) of the current Data Coordinating Center (DCC) for Type 1 Diabetes Acute Pancreatitis Consortium (T1DAPC). This 5-year longitudinal observational clinical study was originally funded in September 2020 and is currently in its planning phase. It will conduct a prospective longitudinal observational study of the occurrence of new onset diabetes during an acute pancreatitis (AP) episode or subsequently, with an emphasis on type 1 diabetes (T1D). The study is designed to gain insight into the incidence, clinical evolution, etiology, type and pathophysiology of the T1D and other forms of diabetes after AP. The DCC is involved in coordination and study design, including data and biosample acquisition and management and is responsible for distribution of funding to the clinical centers for participant costs. This supplement provides funding for the T1DAPC DCC to support longitudinal Magnetic Resonance Imaging (MRI) and other types of biomarker studies of enrolled participants. Aynur Unalp-Arida, MD, MSc, PhD | RFA-DK-21-501 Notice of Special Interest: Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact 04/05/2021 The goal of this Notice of Special Interest (NOSI) is to strengthen NIH-funded biomedical data repositories to better enable data discoverability, interoperability, and reuse by aligning with the FAIR and TRUST principles and using metrics to measure their effectiveness. This NOSI provides an opportunity for existing repositories to increase "FAIR"-ness and "TRUST"-worthiness to improve their usage, utility, and impact throughout the data resource lifecycle. Fenglou Mao, Ph.D. | NOT-OD-21-089 Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science 04/05/2021 This Notice announces the continuing availability of administrative supplements NOT-OD-20-073 to active awards that focus on biomedical software development or have a significant software development component. The goal of these supplements is to invest in research software tools with recognized value in a scientific community to enhance their impact by leveraging best practices in software development and advances in cloud computing. This initiative is part of a plan for implementing the NIH Strategic Plan for Data Science which describes actions aimed at modernizing the biomedical research data ecosystem and making data findable, accessible, interoperable, and reusable (FAIR) with high impact for open science. The supplements are intended to support collaborations between biomedical scientists and software engineers to enhance the design, implementation, and "cloud-readiness" of research software. Through these awards, the NIH Office of Data Science Strategy (ODSS) intends to help researchers who have developed scientifically valuable software to make tools sustainable, contribute to open science, and take advantage of new data science and computing paradigms. Office of Data Science Strategy | NOT-OD-21-091 View All Funding Opportunities

To unsubscribe, update your password, or change your email address visit our Subscriber Preference Page. For any questions or problems with this subscription service, please visit the Subscriber Help Center.

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 Information Way, Bethesda, MD 20892 · 1-800-860-8747